- Home
- PERI vs SVRA Comparison
PERI vs SVRA Comparison
Compare PERI & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PERI
- SVRA
- Stock Information
- Founded
- PERI 1999
- SVRA 2007
- Country
- PERI Israel
- SVRA United States
- Employees
- PERI N/A
- SVRA N/A
- Industry
- PERI EDP Services
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- PERI Technology
- SVRA Health Care
- Exchange
- PERI Nasdaq
- SVRA Nasdaq
- Market Cap
- PERI 395.5M
- SVRA 505.8M
- IPO Year
- PERI 2006
- SVRA N/A
- Fundamental
- Price
- PERI $9.63
- SVRA $3.22
- Analyst Decision
- PERI Buy
- SVRA Buy
- Analyst Count
- PERI 4
- SVRA 6
- Target Price
- PERI $9.00
- SVRA $8.83
- AVG Volume (30 Days)
- PERI 496.8K
- SVRA 616.7K
- Earning Date
- PERI 05-13-2025
- SVRA 05-16-2025
- Dividend Yield
- PERI N/A
- SVRA N/A
- EPS Growth
- PERI N/A
- SVRA N/A
- EPS
- PERI 0.25
- SVRA N/A
- Revenue
- PERI $498,286,000.00
- SVRA N/A
- Revenue This Year
- PERI N/A
- SVRA N/A
- Revenue Next Year
- PERI $7.74
- SVRA N/A
- P/E Ratio
- PERI $36.88
- SVRA N/A
- Revenue Growth
- PERI N/A
- SVRA N/A
- 52 Week Low
- PERI $7.00
- SVRA $2.26
- 52 Week High
- PERI $13.49
- SVRA $5.31
- Technical
- Relative Strength Index (RSI)
- PERI 64.07
- SVRA 56.12
- Support Level
- PERI $8.87
- SVRA $3.12
- Resistance Level
- PERI $9.68
- SVRA $3.56
- Average True Range (ATR)
- PERI 0.38
- SVRA 0.18
- MACD
- PERI 0.05
- SVRA -0.02
- Stochastic Oscillator
- PERI 95.37
- SVRA 55.11
About PERI Perion Network Ltd.
Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.